Regulators at the U.S. Food and Drug Administration on Friday granted emergency authorization to Pfizer’s COVID-19 vaccine for 5- to 11-year-olds, a step that means kid-sized doses can begin shipping to health care providers across the country. The Centers for Disease Control’s panel of vaccine experts is scheduled to meet Tuesday to discuss guidelines for the vaccine’s use in the younger age group.
Vaccines for kids
The next wave of the massive COVID-19 vaccination campaign could begin as soon as next week, after federal regulators decide if elementary school students across the U.S. should begin rolling up their tiny sleeves.